nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—DDC—Parkinson's disease	0.315	0.413	CbGaD
Amantadine—GRIN2B—Parkinson's disease	0.194	0.254	CbGaD
Amantadine—MAOB—Parkinson's disease	0.152	0.199	CbGaD
Amantadine—DRD2—Parkinson's disease	0.0681	0.0892	CbGaD
Amantadine—ABCB1—Parkinson's disease	0.0344	0.045	CbGaD
Amantadine—GRIN1—telencephalic ventricle—Parkinson's disease	0.00404	0.0473	CbGeAlD
Amantadine—GRIN2B—telencephalic ventricle—Parkinson's disease	0.00385	0.0451	CbGeAlD
Amantadine—DDC—telencephalic ventricle—Parkinson's disease	0.00315	0.0369	CbGeAlD
Amantadine—GRIN2C—nerve—Parkinson's disease	0.00307	0.036	CbGeAlD
Amantadine—GRIN2B—nerve—Parkinson's disease	0.00243	0.0285	CbGeAlD
Amantadine—GRIN2C—hindbrain—Parkinson's disease	0.0023	0.027	CbGeAlD
Amantadine—GRIN2D—hindbrain—Parkinson's disease	0.00214	0.0251	CbGeAlD
Amantadine—GRIN2A—nerve—Parkinson's disease	0.00212	0.0249	CbGeAlD
Amantadine—DDC—nerve—Parkinson's disease	0.00198	0.0232	CbGeAlD
Amantadine—GRIN1—hindbrain—Parkinson's disease	0.00191	0.0223	CbGeAlD
Amantadine—GRIN2B—hindbrain—Parkinson's disease	0.00182	0.0213	CbGeAlD
Amantadine—GRIN2A—hindbrain—Parkinson's disease	0.00159	0.0186	CbGeAlD
Amantadine—DDC—hindbrain—Parkinson's disease	0.00149	0.0174	CbGeAlD
Amantadine—DRD2—telencephalic ventricle—Parkinson's disease	0.00137	0.016	CbGeAlD
Amantadine—GRIN2C—brainstem—Parkinson's disease	0.00132	0.0155	CbGeAlD
Amantadine—GRIN2C—forebrain—Parkinson's disease	0.00127	0.0149	CbGeAlD
Amantadine—GRIN2D—brainstem—Parkinson's disease	0.00123	0.0144	CbGeAlD
Amantadine—GRIN2D—forebrain—Parkinson's disease	0.00118	0.0139	CbGeAlD
Amantadine—GRIN3A—forebrain—Parkinson's disease	0.00111	0.013	CbGeAlD
Amantadine—GRIN1—brainstem—Parkinson's disease	0.00109	0.0128	CbGeAlD
Amantadine—GRIN1—forebrain—Parkinson's disease	0.00106	0.0124	CbGeAlD
Amantadine—GRIN2B—brainstem—Parkinson's disease	0.00104	0.0122	CbGeAlD
Amantadine—MAOB—nerve—Parkinson's disease	0.00102	0.012	CbGeAlD
Amantadine—GRIN2B—forebrain—Parkinson's disease	0.00101	0.0118	CbGeAlD
Amantadine—DDC—embryo—Parkinson's disease	0.00093	0.0109	CbGeAlD
Amantadine—GRIN2C—medulla oblongata—Parkinson's disease	0.00092	0.0108	CbGeAlD
Amantadine—GRIN2A—brainstem—Parkinson's disease	0.000912	0.0107	CbGeAlD
Amantadine—GRIN2A—forebrain—Parkinson's disease	0.00088	0.0103	CbGeAlD
Amantadine—DRD2—nerve—Parkinson's disease	0.000861	0.0101	CbGeAlD
Amantadine—GRIN2D—medulla oblongata—Parkinson's disease	0.000855	0.01	CbGeAlD
Amantadine—DDC—brainstem—Parkinson's disease	0.000852	0.00997	CbGeAlD
Amantadine—DDC—forebrain—Parkinson's disease	0.000822	0.00963	CbGeAlD
Amantadine—MAOB—hindbrain—Parkinson's disease	0.000765	0.00895	CbGeAlD
Amantadine—GRIN2D—spinal cord—Parkinson's disease	0.000763	0.00893	CbGeAlD
Amantadine—GRIN2C—head—Parkinson's disease	0.000729	0.00854	CbGeAlD
Amantadine—GRIN1—midbrain—Parkinson's disease	0.000697	0.00816	CbGeAlD
Amantadine—GRIN2C—nervous system—Parkinson's disease	0.000691	0.0081	CbGeAlD
Amantadine—GRIN1—spinal cord—Parkinson's disease	0.00068	0.00796	CbGeAlD
Amantadine—GRIN2D—head—Parkinson's disease	0.000678	0.00794	CbGeAlD
Amantadine—GRIN2C—central nervous system—Parkinson's disease	0.000666	0.00779	CbGeAlD
Amantadine—GRIN2C—cerebellum—Parkinson's disease	0.000651	0.00762	CbGeAlD
Amantadine—GRIN2B—spinal cord—Parkinson's disease	0.000649	0.00759	CbGeAlD
Amantadine—DRD2—hindbrain—Parkinson's disease	0.000645	0.00755	CbGeAlD
Amantadine—GRIN2D—nervous system—Parkinson's disease	0.000643	0.00753	CbGeAlD
Amantadine—GRIN3A—head—Parkinson's disease	0.000637	0.00746	CbGeAlD
Amantadine—GRIN2A—medulla oblongata—Parkinson's disease	0.000636	0.00744	CbGeAlD
Amantadine—GRIN2D—central nervous system—Parkinson's disease	0.000619	0.00725	CbGeAlD
Amantadine—GRIN2D—cerebellum—Parkinson's disease	0.000605	0.00708	CbGeAlD
Amantadine—GRIN3A—nervous system—Parkinson's disease	0.000604	0.00708	CbGeAlD
Amantadine—GRIN1—head—Parkinson's disease	0.000604	0.00708	CbGeAlD
Amantadine—GRIN3A—central nervous system—Parkinson's disease	0.000582	0.00681	CbGeAlD
Amantadine—GRIN2A—midbrain—Parkinson's disease	0.000581	0.0068	CbGeAlD
Amantadine—GRIN2B—head—Parkinson's disease	0.000576	0.00675	CbGeAlD
Amantadine—GRIN1—nervous system—Parkinson's disease	0.000573	0.00671	CbGeAlD
Amantadine—GRIN2A—spinal cord—Parkinson's disease	0.000567	0.00664	CbGeAlD
Amantadine—GRIN1—central nervous system—Parkinson's disease	0.000552	0.00646	CbGeAlD
Amantadine—GRIN2B—nervous system—Parkinson's disease	0.000547	0.0064	CbGeAlD
Amantadine—DDC—midbrain—Parkinson's disease	0.000543	0.00636	CbGeAlD
Amantadine—GRIN1—cerebellum—Parkinson's disease	0.000539	0.00631	CbGeAlD
Amantadine—GRIN2C—brain—Parkinson's disease	0.000528	0.00619	CbGeAlD
Amantadine—GRIN2B—central nervous system—Parkinson's disease	0.000526	0.00616	CbGeAlD
Amantadine—GRIN2B—cerebellum—Parkinson's disease	0.000514	0.00602	CbGeAlD
Amantadine—GRIN2A—head—Parkinson's disease	0.000504	0.0059	CbGeAlD
Amantadine—GRIN2D—brain—Parkinson's disease	0.000491	0.00575	CbGeAlD
Amantadine—SLC22A1—forebrain—Parkinson's disease	0.000478	0.0056	CbGeAlD
Amantadine—MAOB—embryo—Parkinson's disease	0.000478	0.0056	CbGeAlD
Amantadine—GRIN2A—nervous system—Parkinson's disease	0.000478	0.00559	CbGeAlD
Amantadine—DDC—head—Parkinson's disease	0.000471	0.00551	CbGeAlD
Amantadine—GRIN3A—brain—Parkinson's disease	0.000462	0.00541	CbGeAlD
Amantadine—GRIN2A—central nervous system—Parkinson's disease	0.00046	0.00539	CbGeAlD
Amantadine—GRIN2A—cerebellum—Parkinson's disease	0.00045	0.00526	CbGeAlD
Amantadine—DDC—nervous system—Parkinson's disease	0.000446	0.00523	CbGeAlD
Amantadine—MAOB—brainstem—Parkinson's disease	0.000438	0.00513	CbGeAlD
Amantadine—GRIN1—brain—Parkinson's disease	0.000438	0.00513	CbGeAlD
Amantadine—DDC—central nervous system—Parkinson's disease	0.00043	0.00503	CbGeAlD
Amantadine—MAOB—forebrain—Parkinson's disease	0.000423	0.00495	CbGeAlD
Amantadine—GRIN2B—brain—Parkinson's disease	0.000418	0.00489	CbGeAlD
Amantadine—DRD2—brainstem—Parkinson's disease	0.00037	0.00433	CbGeAlD
Amantadine—GRIN2A—brain—Parkinson's disease	0.000365	0.00428	CbGeAlD
Amantadine—MAOB—cardiovascular system—Parkinson's disease	0.000358	0.00419	CbGeAlD
Amantadine—DRD2—forebrain—Parkinson's disease	0.000357	0.00418	CbGeAlD
Amantadine—DDC—brain—Parkinson's disease	0.000341	0.00399	CbGeAlD
Amantadine—SIGMAR1—medulla oblongata—Parkinson's disease	0.000319	0.00374	CbGeAlD
Amantadine—MAOB—medulla oblongata—Parkinson's disease	0.000306	0.00358	CbGeAlD
Amantadine—SIGMAR1—midbrain—Parkinson's disease	0.000292	0.00342	CbGeAlD
Amantadine—SIGMAR1—spinal cord—Parkinson's disease	0.000285	0.00333	CbGeAlD
Amantadine—MAOB—midbrain—Parkinson's disease	0.000279	0.00327	CbGeAlD
Amantadine—SLC22A1—head—Parkinson's disease	0.000274	0.00321	CbGeAlD
Amantadine—MAOB—spinal cord—Parkinson's disease	0.000272	0.00319	CbGeAlD
Amantadine—SLC22A1—nervous system—Parkinson's disease	0.00026	0.00304	CbGeAlD
Amantadine—SLC22A1—central nervous system—Parkinson's disease	0.00025	0.00293	CbGeAlD
Amantadine—MAOB—head—Parkinson's disease	0.000242	0.00284	CbGeAlD
Amantadine—DRD2—midbrain—Parkinson's disease	0.000236	0.00276	CbGeAlD
Amantadine—MAOB—nervous system—Parkinson's disease	0.00023	0.00269	CbGeAlD
Amantadine—SIGMAR1—cerebellum—Parkinson's disease	0.000226	0.00264	CbGeAlD
Amantadine—MAOB—central nervous system—Parkinson's disease	0.000221	0.00259	CbGeAlD
Amantadine—MAOB—cerebellum—Parkinson's disease	0.000216	0.00253	CbGeAlD
Amantadine—DRD2—head—Parkinson's disease	0.000204	0.00239	CbGeAlD
Amantadine—SLC22A1—brain—Parkinson's disease	0.000198	0.00232	CbGeAlD
Amantadine—DRD2—nervous system—Parkinson's disease	0.000194	0.00227	CbGeAlD
Amantadine—DRD2—central nervous system—Parkinson's disease	0.000187	0.00218	CbGeAlD
Amantadine—SIGMAR1—brain—Parkinson's disease	0.000183	0.00215	CbGeAlD
Amantadine—DRD2—cerebellum—Parkinson's disease	0.000182	0.00213	CbGeAlD
Amantadine—MAOB—brain—Parkinson's disease	0.000175	0.00205	CbGeAlD
Amantadine—ABCB1—embryo—Parkinson's disease	0.000174	0.00204	CbGeAlD
Amantadine—ABCB1—forebrain—Parkinson's disease	0.000154	0.00181	CbGeAlD
Amantadine—DRD2—brain—Parkinson's disease	0.000148	0.00173	CbGeAlD
Amantadine—ABCB1—cardiovascular system—Parkinson's disease	0.00013	0.00153	CbGeAlD
Amantadine—ABCB1—medulla oblongata—Parkinson's disease	0.000111	0.00131	CbGeAlD
Amantadine—ABCB1—midbrain—Parkinson's disease	0.000102	0.00119	CbGeAlD
Amantadine—ABCB1—spinal cord—Parkinson's disease	9.94e-05	0.00116	CbGeAlD
Amantadine—ABCB1—head—Parkinson's disease	8.83e-05	0.00103	CbGeAlD
Amantadine—ABCB1—nervous system—Parkinson's disease	8.37e-05	0.000981	CbGeAlD
Amantadine—ABCB1—central nervous system—Parkinson's disease	8.06e-05	0.000944	CbGeAlD
Amantadine—ABCB1—cerebellum—Parkinson's disease	7.88e-05	0.000923	CbGeAlD
Amantadine—ABCB1—brain—Parkinson's disease	6.4e-05	0.000749	CbGeAlD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	2.58e-05	0.000171	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	2.57e-05	0.00017	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—IL6—Parkinson's disease	2.55e-05	0.000169	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	2.53e-05	0.000167	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—DGKQ—Parkinson's disease	2.52e-05	0.000167	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—GPR37—Parkinson's disease	2.52e-05	0.000167	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	2.52e-05	0.000167	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	2.44e-05	0.000162	CbGpPWpGaD
Amantadine—DDC—Metabolism—PLA2G6—Parkinson's disease	2.4e-05	0.000159	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—IL6—Parkinson's disease	2.38e-05	0.000157	CbGpPWpGaD
Amantadine—MAOB—Metabolism—DDC—Parkinson's disease	2.38e-05	0.000157	CbGpPWpGaD
Amantadine—DDC—Metabolism—MAOB—Parkinson's disease	2.38e-05	0.000157	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—COMT—Parkinson's disease	2.37e-05	0.000157	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—MAOA—Parkinson's disease	2.36e-05	0.000156	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	2.36e-05	0.000156	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	2.36e-05	0.000156	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PPP1R1B—Parkinson's disease	2.31e-05	0.000153	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—ADORA2A—Parkinson's disease	2.29e-05	0.000152	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	2.29e-05	0.000151	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ND3—Parkinson's disease	2.27e-05	0.00015	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—MCCC1—Parkinson's disease	2.27e-05	0.00015	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GSTA4—Parkinson's disease	2.24e-05	0.000148	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—COMT—Parkinson's disease	2.21e-05	0.000146	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	2.21e-05	0.000146	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—MAOA—Parkinson's disease	2.2e-05	0.000145	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	2.13e-05	0.000141	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—TALDO1—Parkinson's disease	2.13e-05	0.000141	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—OMD—Parkinson's disease	2.13e-05	0.000141	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ND3—Parkinson's disease	2.11e-05	0.00014	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—MCCC1—Parkinson's disease	2.11e-05	0.00014	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—CP—Parkinson's disease	2.11e-05	0.000139	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—GRK5—Parkinson's disease	2.11e-05	0.000139	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	2.04e-05	0.000135	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—NDUFB11—Parkinson's disease	2.02e-05	0.000134	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PLA2G6—Parkinson's disease	2.02e-05	0.000134	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—HTR1A—Parkinson's disease	1.99e-05	0.000132	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—TALDO1—Parkinson's disease	1.99e-05	0.000131	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—OMD—Parkinson's disease	1.99e-05	0.000131	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—CP—Parkinson's disease	1.96e-05	0.00013	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—TAC1—Parkinson's disease	1.96e-05	0.00013	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—IL6—Parkinson's disease	1.94e-05	0.000128	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GCH1—Parkinson's disease	1.93e-05	0.000128	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—DRD1—Parkinson's disease	1.92e-05	0.000127	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—GRK5—Parkinson's disease	1.91e-05	0.000127	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—GRM4—Parkinson's disease	1.89e-05	0.000125	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—NDUFB11—Parkinson's disease	1.88e-05	0.000125	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—DRD3—Parkinson's disease	1.86e-05	0.000123	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—INS—Parkinson's disease	1.86e-05	0.000123	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—INS—Parkinson's disease	1.81e-05	0.00012	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	1.8e-05	0.000119	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—VPS35—Parkinson's disease	1.8e-05	0.000119	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GCH1—Parkinson's disease	1.8e-05	0.000119	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PENK—Parkinson's disease	1.79e-05	0.000119	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	1.77e-05	0.000117	CbGpPWpGaD
Amantadine—DDC—Metabolism—CYP2D6—Parkinson's disease	1.77e-05	0.000117	CbGpPWpGaD
Amantadine—DDC—Metabolism—CTGF—Parkinson's disease	1.73e-05	0.000115	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—FBP1—Parkinson's disease	1.72e-05	0.000114	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—DBH—Parkinson's disease	1.72e-05	0.000114	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GBA—Parkinson's disease	1.72e-05	0.000114	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—GRM4—Parkinson's disease	1.71e-05	0.000114	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	1.71e-05	0.000113	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	1.71e-05	0.000113	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	1.7e-05	0.000113	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	1.68e-05	0.000111	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—HTR7—Parkinson's disease	1.68e-05	0.000111	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PDYN—Parkinson's disease	1.64e-05	0.000108	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PENK—Parkinson's disease	1.63e-05	0.000108	CbGpPWpGaD
Amantadine—DDC—Metabolism—CYP2E1—Parkinson's disease	1.61e-05	0.000107	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GBA—Parkinson's disease	1.6e-05	0.000106	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—DBH—Parkinson's disease	1.6e-05	0.000106	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—FBP1—Parkinson's disease	1.6e-05	0.000106	CbGpPWpGaD
Amantadine—DDC—Metabolism—NQO1—Parkinson's disease	1.6e-05	0.000106	CbGpPWpGaD
Amantadine—DDC—Metabolism—TH—Parkinson's disease	1.57e-05	0.000104	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	1.55e-05	0.000102	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—GRM5—Parkinson's disease	1.52e-05	0.000101	CbGpPWpGaD
Amantadine—DDC—Metabolism—CYCS—Parkinson's disease	1.51e-05	0.0001	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	1.5e-05	9.93e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	1.49e-05	9.88e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—DGKQ—Parkinson's disease	1.49e-05	9.87e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GPR37—Parkinson's disease	1.49e-05	9.87e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PDYN—Parkinson's disease	1.49e-05	9.84e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CYP2D6—Parkinson's disease	1.49e-05	9.84e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CTGF—Parkinson's disease	1.46e-05	9.65e-05	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	1.44e-05	9.54e-05	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	1.4e-05	9.26e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—GRM5—Parkinson's disease	1.38e-05	9.15e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PPP1R1B—Parkinson's disease	1.36e-05	9.02e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CYP2E1—Parkinson's disease	1.36e-05	9e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—EDN1—Parkinson's disease	1.35e-05	8.91e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—NQO1—Parkinson's disease	1.34e-05	8.89e-05	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	1.34e-05	8.89e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—COMT—Parkinson's disease	1.34e-05	8.86e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—GSTP1—Parkinson's disease	1.33e-05	8.81e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—MAOA—Parkinson's disease	1.33e-05	8.79e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—TH—Parkinson's disease	1.32e-05	8.77e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—HMOX1—Parkinson's disease	1.31e-05	8.69e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—ADORA2A—Parkinson's disease	1.29e-05	8.57e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CYCS—Parkinson's disease	1.27e-05	8.42e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—DDC—Parkinson's disease	1.26e-05	8.34e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—ABCB1—Parkinson's disease	1.26e-05	8.34e-05	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	1.25e-05	8.29e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	1.25e-05	8.27e-05	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—TNF—Parkinson's disease	1.24e-05	8.2e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—MCCC1—Parkinson's disease	1.24e-05	8.19e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ND3—Parkinson's disease	1.24e-05	8.19e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—GSTM1—Parkinson's disease	1.22e-05	8.1e-05	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	1.2e-05	7.96e-05	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—MAPK8—Parkinson's disease	1.2e-05	7.93e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RIT2—Parkinson's disease	1.19e-05	7.89e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GSTA4—Parkinson's disease	1.19e-05	7.88e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—HTR2A—Parkinson's disease	1.18e-05	7.79e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—ADORA2A—Parkinson's disease	1.18e-05	7.78e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—DDC—Parkinson's disease	1.17e-05	7.78e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—GPX1—Parkinson's disease	1.17e-05	7.76e-05	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	1.17e-05	7.73e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—TALDO1—Parkinson's disease	1.16e-05	7.7e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—OMD—Parkinson's disease	1.16e-05	7.7e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	1.15e-05	7.62e-05	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—IL6—Parkinson's disease	1.14e-05	7.53e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GRK5—Parkinson's disease	1.13e-05	7.48e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—COMT—Parkinson's disease	1.13e-05	7.45e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—HTR1A—Parkinson's disease	1.12e-05	7.43e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GSTP1—Parkinson's disease	1.12e-05	7.42e-05	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	1.12e-05	7.42e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—MAOA—Parkinson's disease	1.12e-05	7.4e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GSTA4—Parkinson's disease	1.11e-05	7.34e-05	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—IL6—Parkinson's disease	1.11e-05	7.34e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—TAC1—Parkinson's disease	1.11e-05	7.32e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—HMOX1—Parkinson's disease	1.11e-05	7.32e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—NDUFB11—Parkinson's disease	1.1e-05	7.3e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—DRD1—Parkinson's disease	1.08e-05	7.18e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—MTHFR—Parkinson's disease	1.08e-05	7.16e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PLA2G6—Parkinson's disease	1.07e-05	7.09e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—MAOB—Parkinson's disease	1.06e-05	7.02e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—ABCB1—Parkinson's disease	1.06e-05	7.02e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GCH1—Parkinson's disease	1.05e-05	6.97e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—DRD3—Parkinson's disease	1.05e-05	6.95e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GSTM1—Parkinson's disease	1.03e-05	6.82e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HTR1A—Parkinson's disease	1.02e-05	6.75e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GRM4—Parkinson's disease	1.01e-05	6.71e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—APOE—Parkinson's disease	1.01e-05	6.66e-05	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—TNF—Parkinson's disease	1.01e-05	6.66e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—TAC1—Parkinson's disease	1e-05	6.65e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PLA2G6—Parkinson's disease	9.99e-06	6.61e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—MAOB—Parkinson's disease	9.89e-06	6.55e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GPX1—Parkinson's disease	9.86e-06	6.53e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—DRD1—Parkinson's disease	9.85e-06	6.52e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—ADRBK1—Parkinson's disease	9.81e-06	6.49e-05	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—TNF—Parkinson's disease	9.81e-06	6.49e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PENK—Parkinson's disease	9.6e-06	6.36e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MAG—Parkinson's disease	9.6e-06	6.36e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—DRD3—Parkinson's disease	9.54e-06	6.31e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—HTR7—Parkinson's disease	9.5e-06	6.29e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GBA—Parkinson's disease	9.38e-06	6.21e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—DBH—Parkinson's disease	9.38e-06	6.21e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—FBP1—Parkinson's disease	9.38e-06	6.21e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—MTHFR—Parkinson's disease	9.1e-06	6.03e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—ADRBK1—Parkinson's disease	8.91e-06	5.9e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PDYN—Parkinson's disease	8.78e-06	5.81e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HTR7—Parkinson's disease	8.63e-06	5.71e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—INS—Parkinson's disease	8.6e-06	5.69e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—APOE—Parkinson's disease	8.47e-06	5.61e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	8.4e-06	5.56e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GFAP—Parkinson's disease	8.26e-06	5.47e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	8.2e-06	5.43e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GRM5—Parkinson's disease	8.17e-06	5.41e-05	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—IL6—Parkinson's disease	8.12e-06	5.37e-05	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—IL6—Parkinson's disease	7.91e-06	5.24e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CYP2D6—Parkinson's disease	7.88e-06	5.22e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	7.87e-06	5.21e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CTGF—Parkinson's disease	7.74e-06	5.12e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	7.72e-06	5.11e-05	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—IL6—Parkinson's disease	7.65e-06	5.06e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—EDN1—Parkinson's disease	7.61e-06	5.03e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CYP2D6—Parkinson's disease	7.35e-06	4.86e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—INS—Parkinson's disease	7.24e-06	4.79e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CTGF—Parkinson's disease	7.21e-06	4.78e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CYP2E1—Parkinson's disease	7.21e-06	4.77e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FGF20—Parkinson's disease	7.16e-06	4.74e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—NQO1—Parkinson's disease	7.13e-06	4.72e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—TH—Parkinson's disease	7.03e-06	4.65e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ADORA2A—Parkinson's disease	6.94e-06	4.6e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—EDN1—Parkinson's disease	6.91e-06	4.57e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—DDC—Parkinson's disease	6.89e-06	4.56e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	6.84e-06	4.53e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CYCS—Parkinson's disease	6.75e-06	4.47e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CYP2E1—Parkinson's disease	6.72e-06	4.45e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—HTR2A—Parkinson's disease	6.65e-06	4.4e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—NQO1—Parkinson's disease	6.65e-06	4.4e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—TH—Parkinson's disease	6.55e-06	4.34e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTA4—Parkinson's disease	6.5e-06	4.3e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—INSR—Parkinson's disease	6.41e-06	4.24e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CYCS—Parkinson's disease	6.29e-06	4.16e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	6.11e-06	4.04e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FGB—Parkinson's disease	6.06e-06	4.01e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HTR2A—Parkinson's disease	6.04e-06	4e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR1A—Parkinson's disease	6.02e-06	3.99e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—COMT—Parkinson's disease	5.98e-06	3.96e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GSTP1—Parkinson's disease	5.95e-06	3.94e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—MAOA—Parkinson's disease	5.93e-06	3.93e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TAC1—Parkinson's disease	5.93e-06	3.93e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—HMOX1—Parkinson's disease	5.87e-06	3.88e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PLA2G6—Parkinson's disease	5.85e-06	3.88e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—DRD1—Parkinson's disease	5.82e-06	3.85e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—MAOB—Parkinson's disease	5.8e-06	3.84e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—DRD3—Parkinson's disease	5.64e-06	3.73e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ABCB1—Parkinson's disease	5.63e-06	3.73e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—COMT—Parkinson's disease	5.57e-06	3.69e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GSTP1—Parkinson's disease	5.54e-06	3.67e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—MAOA—Parkinson's disease	5.53e-06	3.66e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—HMOX1—Parkinson's disease	5.47e-06	3.62e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GSTM1—Parkinson's disease	5.47e-06	3.62e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	5.26e-06	3.48e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ABCB1—Parkinson's disease	5.25e-06	3.47e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GPX1—Parkinson's disease	5.23e-06	3.46e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR7—Parkinson's disease	5.1e-06	3.37e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GSTM1—Parkinson's disease	5.09e-06	3.37e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GPX1—Parkinson's disease	4.88e-06	3.23e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—MTHFR—Parkinson's disease	4.83e-06	3.2e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—MTHFR—Parkinson's disease	4.5e-06	2.98e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—APOE—Parkinson's disease	4.5e-06	2.98e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP2D6—Parkinson's disease	4.31e-06	2.85e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IGF2—Parkinson's disease	4.27e-06	2.83e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CTGF—Parkinson's disease	4.23e-06	2.8e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—APOE—Parkinson's disease	4.19e-06	2.77e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	4.13e-06	2.73e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—EDN1—Parkinson's disease	4.08e-06	2.7e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP2E1—Parkinson's disease	3.94e-06	2.61e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—NQO1—Parkinson's disease	3.9e-06	2.58e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—INS—Parkinson's disease	3.84e-06	2.54e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—TH—Parkinson's disease	3.84e-06	2.54e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NGF—Parkinson's disease	3.75e-06	2.48e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYCS—Parkinson's disease	3.69e-06	2.44e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—INS—Parkinson's disease	3.58e-06	2.37e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	3.57e-06	2.36e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—APOE—Parkinson's disease	3.32e-06	2.2e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—COMT—Parkinson's disease	3.26e-06	2.16e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTP1—Parkinson's disease	3.25e-06	2.15e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—MAOA—Parkinson's disease	3.24e-06	2.15e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—HMOX1—Parkinson's disease	3.2e-06	2.12e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTM1—Parkinson's disease	2.99e-06	1.98e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GPX1—Parkinson's disease	2.86e-06	1.89e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—INS—Parkinson's disease	2.83e-06	1.88e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—MTHFR—Parkinson's disease	2.64e-06	1.75e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—APOE—Parkinson's disease	2.46e-06	1.63e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CASP3—Parkinson's disease	2.11e-06	1.4e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—INS—Parkinson's disease	2.1e-06	1.39e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—IL6—Parkinson's disease	2.1e-06	1.39e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	1.94e-06	1.28e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IL6—Parkinson's disease	1.24e-06	8.2e-06	CbGpPWpGaD
